Compared with hormone naïve PCa, ARΔLBDs are frequently upregulated in CRPC, and may serve as an adaptive response to therapies targeting the androgen/AR-signaling axis (Guo et al., 2009; Li et al., 2013). The gene discussed is AR; the disease is posterior cortical atrophy.